nafamostat has been researched along with Infections, Chlamydia in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effective treatment of reactive arthritis would ideally achieve both control of inflammation and eradication of persisting arthritogenic pathogens." | 1.38 | Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis. ( Chiu, B; Inman, RD, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, L | 1 |
| Zhang, H | 1 |
| Hu, Z | 1 |
| Zhao, Y | 1 |
| Liu, S | 1 |
| Chen, J | 1 |
| Inman, RD | 1 |
| Chiu, B | 1 |
2 other studies available for nafamostat and Infections, Chlamydia
| Article | Year |
|---|---|
Nafamostat mesylate inhibits chlamydial intracellular growth in cell culture and reduces chlamydial infection in the mouse genital tract.
Topics: Animals; Benzamidines; Cell Culture Techniques; Chlamydia Infections; Chlamydia trachomatis; Female; | 2020 |
Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis.
Topics: Animals; Anti-Infective Agents; Arthritis, Experimental; Arthritis, Reactive; Benzamidines; Chlamydi | 2012 |